A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 566 participants.

Also called NCT07523750

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 566 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07523750
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07523750. Randomized; no masking; primary purpose treatment. Start 2026-04-02 (actual); primary completion 2028-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
Acronym
PERSIGMA RCT
Intervention (Device)
VARIPULSE Catheter
Intervention (Device)
FARAWAVE Catheter
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07523750
Content hash
5b328c1a2c8974855cbe9ae8d0c29248dbca63d44882a0c858186e6d7b364428